National Institute of General Medical Sciences; Notice of Closed Meetings, 54907-54908 [2019-22237]

Download as PDF 54907 Federal Register / Vol. 84, No. 198 / Friday, October 11, 2019 / Notices SUPPLEMENTARY INFORMATION: Information Collection Request Title: Ryan White HIV/AIDS Program Core Medical Services Waiver Application Requirements, OMB No. 0915–0307— Extension. Abstract: Title XXVI of the Public Health Service (PHS) Act, as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009, also known as the Ryan White HIV/AIDS Program (RWHAP), requires that grant recipients expend funds on core medical services including antiretroviral drugs for individuals with HIV who are eligible under the statute. In addition, after reserving statutory permissible amounts for administrative and clinical quality management costs from the total award amount, at least 75 percent of the remainder is to be expended on core medical services.1 For a grant recipient under the RWHAP Parts A, B, or C to be exempted from this requirement, a waiver must be requested from HRSA for review and approval in accordance with statute. On October 25, 2013, HRSA published revised standards for core medical services waiver requests in the Federal Register (78 FR 63990). These revised standards allow grant recipients flexibility to adjust resource allocation based on the current situation in their local environments. These standards ensure that grant recipients receiving waivers demonstrate the availability of core medical services, including antiretroviral drugs, for persons with HIV served under the HRSA RWHAP. The core medical services waiver request process applies to RWHAP grant applicants and recipients under Parts A, B, and C of Title XXVI of the PHS Act. Core medical services waivers are effective for a 1-year period. Grant applicants may submit a waiver request before, or with the annual grant application, and grant recipients can submit up to four months after the grant award has been made. A 60-day notice was published in the Federal Register on August 15, 2019, vol. 84, No. 158; pp. 41726–27. There were no public comments. Need and Proposed Use of the Information: HRSA uses the documentation submitted in core medical services waiver requests to determine if the grant applicant or recipient meets the statutory requirements for waiver eligibility including: (1) No waiting lists for AIDS Drug Assistance Program services; and (2) evidence of core medical services availability within the grant recipient’s jurisdiction, state, or service area to all persons with HIV identified and eligible under Title XXVI of the PHS Act.2 Likely Respondents: Ryan White HIV/ AIDS Program Parts A, B, and C grant applicants and recipients. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours Waiver Request ................................................................... 20 1 20 5.5 110 Total .............................................................................. 20 ........................ 20 ........................ 110 Maria G. Button, Director, Executive Secretariat. confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. [FR Doc. 2019–22274 Filed 10–10–19; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel Review of NIGMS Support of Competitive Research (SCORE) Award Applications. Date: November 8, 2019. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 1 Sections 2604(c)(1), 2612(b)(1), and 2651(c)(1) of the PHS Act. 2 Sections 2604(c)(2), 2612(b)(2), and 2651(c)(2) of the PHS Act. National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings jbell on DSK3GLQ082PROD with NOTICES Number of responses per respondent VerDate Sep<11>2014 17:56 Oct 10, 2019 Jkt 250001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Natcher Building, Room 3AN18C, 45 Center Drive, Bethesda, MD 20892, (301) 594–2771, johnsonrh@nigms.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Review of Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24) Applications. Date: November 13, 2019. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN18C, 45 Center Drive, Bethesda, MD 20892, (301) 594–2771 johnsonrh@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical E:\FR\FM\11OCN1.SGM 11OCN1 54908 Federal Register / Vol. 84, No. 198 / Friday, October 11, 2019 / Notices Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: October 7, 2019. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–22237 Filed 10–10–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Draft NTP Technical Reports on Toxicology and Carcinogenesis Studies of HMB and PFOA; Availability of Documents; Request for Comments; Notice of Peer-Review Meeting AGENCY: National Institutes of Health, HHS. jbell on DSK3GLQ082PROD with NOTICES ACTION: Notice. SUMMARY: The National Toxicology Program (NTP) announces the availability of two draft NTP Technical Reports on toxicology and carcinogenesis studies scheduled for peer review for the following substances: 2-hydroxy-4methoxybenzophenone and perfluorooctanoic acid. The peer-review meeting will be held by webcast only and available to the public for remote viewing. Registration is required for attendance by webcast and to present oral comments. Information about the meeting and registration is available at https://ntp.niehs.nih.gov/go/36051. DATES: Meeting: December 12, 2019, 10:00 a.m. Eastern Standard Time (EST) to adjournment. The meeting may end earlier or later than 5:00 p.m. EST. Document Availability: The two draft NTP reports will be available by October 15, 2019 at https://ntp.niehs.nih.gov/go/ 36051. Written Public Comment Submissions: Deadline is November 20, 2019. Registration for Oral Comments: Deadline is December 3, 2019. Registration to View Webcast: Deadline is December 12, 2019. ADDRESSES: Meeting Location: Webcast. Meeting Web Page: The draft reports, preliminary agenda, registration, and other meeting materials will be available at https://ntp.niehs.nih.gov/go/36051. VerDate Sep<11>2014 17:56 Oct 10, 2019 Jkt 250001 Webcast: The URL for viewing the peer-review meeting webcast will be provided to registrants. FOR FURTHER INFORMATION CONTACT: Email NTP-Meetings@icf.com. Dr. Elizabeth Maull, NIEHS/DNTP, is the Designated Federal Official. Phone: (984) 287–3157, Fax: (301) 480–3008. Email: maull@niehs.nih.gov. SUPPLEMENTARY INFORMATION: Meeting Attendance Registration: The meeting is open to the public with time set aside for oral public comment. Registration to view the webcast is by December 12, 2019, at https:// ntp.niehs.nih.gov/go/36051. The URL for the webcast will be provided in the email confirming registration. Individuals with disabilities who need accommodation to view the webcast should contact Sophie Hearn by phone: (919) 293–1648 or email: NTPMeetings@icf.com. TTY users should contact the Federal TTY Relay Service at (800) 877–8339. Requests should be made at least five business days in advance of the event. Request for Comments: NTP invites written and oral public comments on the draft reports that address scientific or technical issues. Guidelines for public comments are available at https://ntp.niehs.nih.gov/ntp/about_ ntp/guidelines_public_comments_ 508.pdf. The deadline for submission of written comments is November 20, 2019, to enable review by the peerreview panel and NTP staff prior to the meeting. Written public comments should be submitted through the meeting website at https:// ntp.niehs.nih.gov/go/36051. Persons submitting written comments should include name, affiliation, mailing address, phone, email, and sponsoring organization (if any). Written comments received in response to this notice will be posted on the NTP website and the submitter will be identified by name, affiliation, and sponsoring organization (if any). Comments that address scientific/technical issues will be forwarded to the peer-review panel and NTP staff prior to the meeting. Oral public comment at this meeting is welcome, with time set aside for the presentation of oral comments on the draft reports. The agenda will allow for two oral public comment periods—one comment period per report (up to 6 commenters, up to 5 minutes per speaker). Persons wishing to make an oral comment are required to register online at https://ntp.niehs.nih.gov/go/ 36051 by December 3, 2019. Registration is on a first-come, first served basis. Each organization is allowed one time PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 slot per report. The access number for the teleconference line will be provided to registrants by email prior to the meeting. Commenters will be notified approximately one week before the peer-review meeting about the actual time allotted per speaker. If possible, oral public commenters should send a copy of their slides and/ or statement or talking points to Sophie Hearn by email: NTP-Meetings@icf.com by December 3, 2019. Written statements can supplement and may expand the oral presentation. Meeting Materials: The draft NTP reports and preliminary agenda will be available on the NTP website at https:// ntp.niehs.nih.gov/go/36051 prior to the meeting. NTP expects that the draft reports should be available on the website by October 15, 2019. Additional information will be posted when available or may be requested in hardcopy from Sophie Hearn by phone: (919) 293–1648 or email: NTPMeetings@icf.com. Individuals are encouraged to access the meeting web page to stay abreast of the most current information regarding the meeting. Following the meeting, a report of the peer review will be prepared and made available on the NTP website. Background Information on NTP PeerReview Panels: NTP panels are technical, scientific advisory bodies established on an ‘‘as needed’’ basis to provide independent scientific peer review and advise NTP on agents of public health concern, new/revised toxicological test methods, or other issues. These panels help ensure transparent, unbiased, and scientifically rigorous input to the program for its use in making credible decisions about human hazard, setting research and testing priorities, and providing information to regulatory agencies about alternative methods for toxicity screening. NTP welcomes nominations of scientific experts for upcoming panels. Scientists interested in serving on an NTP panel should provide their current curriculum vitae to Sophie Hearn by email: NTP-Meetings@icf.com. The authority for NTP panels is provided by 42 U.S.C. 217a; section 222 of the Public Health Service Act, as amended. The panel is governed by the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. This peer review is being conducted by a panel via webcast. Peer-review of future draft reports will be conducted in accordance with Department of Health and Human Services peer-review policies (https://aspe.hhs.gov/hhsinformation-quality-peer-review) and E:\FR\FM\11OCN1.SGM 11OCN1

Agencies

[Federal Register Volume 84, Number 198 (Friday, October 11, 2019)]
[Notices]
[Pages 54907-54908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22237]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel Review of NIGMS Support of 
Competitive Research (SCORE) Award Applications.
    Date: November 8, 2019.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of General Medical Sciences, Natcher 
Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, Natcher Building, 
Room 3AN18C, 45 Center Drive, Bethesda, MD 20892, (301) 594-2771, 
[email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel, Review of Limited Competition: 
NIGMS Legacy Community-Wide Scientific Resources (R24) Applications.
    Date: November 13, 2019.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of General Medical Sciences, Natcher 
Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, Natcher Building, 
Room 3AN18C, 45 Center Drive, Bethesda, MD 20892, (301) 594-2771 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical

[[Page 54908]]

Research Support; 93.821, Cell Biology and Biophysics Research; 
93.859, Pharmacology, Physiology, and Biological Chemistry Research; 
93.862, Genetics and Developmental Biology Research; 93.88, Minority 
Access to Research Careers; 93.96, Special Minority Initiatives; 
93.859, Biomedical Research and Research Training, National 
Institutes of Health, HHS)

    Dated: October 7, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-22237 Filed 10-10-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.